SCHEMBL532798

SCHEMBL532798

CC(C)(CO)COB(O)c1ccc([Si](c2ccccc2)(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL121398 0.86 DGAT1 (0.36) DGAT1
SCHEMBL4861035 0.84 MGLL (0.43) DGAT1
SCHEMBL14312139 0.80 LPL (0.38)
SCHEMBL17221793 0.77 ORAI1 (0.39)
SCHEMBL14312208 0.76 CA2 (0.40)
1-Heptanol SCHEMBL6701761 0.75 PCSK9 (0.40)
SCHEMBL2112250 0.72 CHRNB2 (0.33)
SCHEMBL5968332 0.70 GSK3B (0.43)
SCHEMBL14659948 0.70 NUDT1 (0.31)
SCHEMBL6902731 0.69 NR5A1 (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2416392-B1 Light emitting device and display unit RICOH CO LTD (JP) 2016-05-25 EP disclosed
US-9263682-B2 Light emitting device and display unit RICOH COMPANY, LTD. (JP) 2016-02-16 US disclosed
US-9206202-B2 Carbazole derivative and semiconductor nanocrystal RICOH COMPANY, LTD. (JP) 2015-12-08 US disclosed
US-20130026426-A1 CARBAZOLE DERIVATIVE AND SEMICONDUCTOR NANOCRYSTAL RICOH COMPANY, LTD. (JP) 2013-01-31 US disclosed
US-20120032115-A1 LIGHT EMITTING DEVICE AND DISPLAY UNIT RICOH COMPANY, LTD. (JP) 2012-02-09 US disclosed
EP-2416392-A2 Light emitting device and display unit Ricoh Company, Ltd. (JP) 2012-02-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130026426-A1 CARBAZOLE DERIVATIVE AND SEMICONDUCTOR NANOCRYSTAL NAT1, AHR, ARSA DGAT1 3619/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.